|
|
CHINA-INI (China International Neuroscience Institute) is internationally renowned for providing highly specialized and innovative care. CRC (cerebral recanalization center), one part of CHINA-INI, specializes in diagnosing and curing ischemic cerebrovascular disease, including carotid artery stenosis, vertebral artery disease, intracranial artery stenosis, moyamoya disease, and so on. By bringing together the world's leading experts in nearly every area of health, we can drive advancements in treatment and technology that benefit patients everywhere.
The CRC team was founded by Prof. Feng Ling, the founder of interventional therapy for cerebrovascular disease in China, and the team members have excellent medical skills and rigorous medical practice. As an essential part of China's neuroscience and neurointerventional science, we are committed to training neurosurgeons, and have trained nearly 1,000 neurosurgeons in China.
Clinic and Education
Publication
The team has long been devoted to researching ischemic cerebrovascular disease-related pathogenesis, diagnostic modalities, and clinical treatments. At present, the research direction of the team involves the carotid artery, vertebral artery, and intracranial artery, and many research results have been published in JAMA and other core journals at home and abroad.
Prof. Feng Ling, the pioneer of interventional therapy for cerebrovascular disease in China, founded the CRC team. The team members have excellent medical skills and adhere to a strict medical practice. As an essential part of China's neuroscience and neurointerventional science, we are committed to training neurosurgeons and have trained nearly 1,000 neurosurgeons in China.
+8615633140085（Site Manager：Dr.Shengyan Cui）
Address：
Xuanwu Hospital, Capital Medical University
45 Chang Chun Street
Xicheng District, Beijing, China
Email：
crcoffical@163.com
wangtao_dr@sina.com (Team Manager Dr.Wang Tao)
Twitter（X）：
Cerebral Recanalization Center CHINA-INI(@sss405084186525)